• H. Lundbeck A/S, of Valby, Denmark, said the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion and recommended marketing authorization for Brintellix (vortioxetine) to treat adults with major depressive episodes, or depression.